pharma
Top Ten most popular articles on Pharmafile.com this week
October 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, biosimilars. GSK, manufacturing, pharma, top 10
Politics played a big role in pharma this week after Trump introduced legislation aimed at reducing the price of drugs. …
Trevena’s opioid injection fails to win over FDA committee
October 12, 2018Medical Communications, Sales and Marketing FDA, Trevena, US, oliceridine, opioid, opioid crisis, pharma
Trevena has seen its opioid injection oliceridine fail to win over an FDA advisory panel in the management of acute …
Roche’s Ocrevus shows earlier, better outcomes in primary progressive and relapsing MS
October 11, 2018Research and Development Ocrevus, Roche, multiple sclerosis, pharma
Roche has unveiled new five-year data from three Phase 3 open-label extension studies investigating the efficacy of Ocrevus (ocrelizumab) in …
NICE recommends first new X-linked hypophosphataemia therapy in over 30 years
October 10, 2018Research and Development, Sales and Marketing Crysvita, Kyowa Kirin International, NHS, NICE, X-linked hypophosphataemia, pharma
NICE has announced its evidence-based recommendation that Kyowa Kirin International’s Crysvita (burosumab) be made available on the NHS for the …
Novartis’ sickle cell drug reduces vaso-occlusive crises by 35% at Phase 2
October 10, 2018Research and Development Novartis, crizanlizumab, pharma, sickle cell disease
Novartis has presented new Phase 2 data for its humanised anti-P-selectin monoclonal antibody crizanlizumab in the treatment of sickle cell …
Janssen’s Stelara shows promise across two dosages in ulcerative colitis
October 9, 2018Manufacturing and Production, Research and Development Janssen, Stelara, pharma, ulcerative colitis
Janssen’s biologic therapy Stelara (ustekinumab) has shown new efficacy in the treatment of moderate to severe ulcerative colitis in two …
Celgene’s Otezla impresses at Phase 3 in scalp psoriasis
October 9, 2018Manufacturing and Production, Research and Development Celgene, pharma, psoriasis
Celgene has unveiled new Phase 3 data for Otezla (apremilast), its inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine …
New hospital-led organisation aims to tackle drug pricing problem by manufacturing generic drugs
October 9, 2018Manufacturing and Production PhRMA, aha, generics, hospitals, non profit, non-profit, pharma
Seven organisations representing around 500 US hospitals have become the governing members of a newly established initiative aimed at reducing …
The economics of mental health
October 8, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HEOR, health economics and outcomes research, mental health, pharma
Louis Goss examines mental health from a health economics and outcomes research (HEOR) perspective and asks what might be done …
NICE recommends Pfizer’s Mylotarg combo in CD33-positive acute myeloid leukaemia
October 8, 2018Sales and Marketing Mylotarg, NICE, Pfizer, acute myeloid leukaemia, leukaemia, pharma
NICE has revealed its recommendation for Pfizer’s Mylotarg (gemtuzumab ozogamicin) to be used on the NHS in the treatment of …
Tech firm Tencent aims for 3-minute Alzheimer’s diagnosis with new partnership
October 8, 2018Research and Development, Sales and Marketing Alzheimer's, pharma, tencent
Chinese tech firm Tencent has partnered up with London-based healthcare technology firm Medopad in a big to accelerate the diagnosis …
GSK to cut almost 200 jobs at UK site
October 5, 2018Manufacturing and Production, Medical Communications GSK, UK, Ulverston, job cuts, pharma
GlaxoSmithKline has announced that it is to slash half of its workforce at its site in Ulverston, UK, as part …
FDA expands indication of Roche’s Hemlibra in haemophilia
October 5, 2018Medical Communications, Sales and Marketing Hemlibra, Roche, haemophilia, pharma
The FDA has chosen to expand the label of Roche’s Hemlibra (emicizumab-kxwh), approving it for routine prophylaxis to prevent the …
Ian Read steps down as Pfizer CEO
October 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Ian Read, Pfizer, pharma
Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …
The value of measuring biotech Board performance
October 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing RSA Group, biotech, board, life sciences, opinion, pharma
Nick Stephens of The RSA Group discusses the importance of stopping to quantify the effectiveness of board members within life …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
